Impending federal budget cuts could mean more than a loss of research money for the University — they could also slow the development of life-saving drugs.
The 2011 Budget Control Act mandated that if deficits were not cut by $1.2 trillion, spending cuts equal to that amount — known as sequestration — would be enacted the next fiscal year. Sequestration went into effect March 1.
Vice Chancellor for Research Barbara Entwisle said that with the cuts, UNC stands to loose an estimated $28 million.
She added that about three-fourths of UNC’s research budget comes from federal funding.
“Clearly this cut will hurt, just as it will hurt every university,” Entwisle said. “It’s happening all over the country. “Right now we’re trying to get ahead of the situation.”
Research grants are won through competitions, most commonly through the National Institutes of Health. Entwisle said the NIH has announced that although it will not cut existing awards, it will reduce the amount of awards that it grants.
“These (researchers) are people who are in the top 10 percent of the competition who aren’t sure if they’ll be getting their grants,” Entwisle said.
One of these researchers is Jian Liu, a professor in the UNC School of Pharmacy, who received NIH funding in 2009 for his work on creating a synthetic version of the blood-thinner heparin.
The funding cycle ended in January, and Liu said if he doesn’t get additional money, residual funds will only support his work for another six months.